Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment

Clinical trial NCT06642844 · RECRUITING

Trial details

NCT number: NCT06642844
Sponsor: University Hospital, Tours
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Unresectable Metastatic Colorectal Cancer

Start date: 2025-03-04
Primary completion: 2028-03-04
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.